Altimmune, Inc. (Nasdaq: ALT) entered into purchase agreements with several institutional investors for the purchase in a registered direct offering ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE